Wombat Capital

About Wombat Capital Founded in 2009, Wombat Capital is a cross-border investment banking and strategic advisory firm providing first class services to entrepreneurs, board of directors, financial investors, private and public companies. By leveraging the industry sector expertise of its bankers, Wombat Capital brings an in-depth understanding of a company's challenges, opportunities and drivers for success and seeks to secure the optimum value and outcome for its clients and their shareholders. Wombat Capital focuses on the lower middle market by providing the following advisory services: ? M&A (buy-side and sell-side) ? Debt and Equity Financing ? Valuation and Fairness Opinion ? Joint Venture ? Strategic Alliances Industry focus: ? Life Sciences and Healthcare: Pharma, Biotech, Contract Services & Outsourcing, Diagnostics, Medical Devices, Healthcare IT Wombat Capital has offices in New York and Paris. Wombat Capital Markets LLC is a registered broker-dealer and member of FINRA (www.finra.org) and SIPC (www.sipc.org). Check the background of our firm and professionals at FINRA Brokercheck (https://brokercheck.finra.org)

网站

https://www.wombatcapital.com

Wombat Capital的外部链接

所属行业

投资银行业务

规模

11-50 人

总部

New York

类型

私人持股

创立

2009

领域

Pharma Licensing Advisory、CMO、Medical Devices、Pharma Outsourcing、Diagnostics、Mergers and Acquisitions、M&A、CRO、API、FDF、Biologics、Small Molecules、Active Pharmaceutical Ingredients、Finished Dosage Form、Drug Products、Drug Substances、Contract Manufacturing Organizations、Contract Research Organizations、CDMO、Buy-side、Sell-side、Life Sciences Tools、Healthcare、Life Sciences、North America、Europe、France、USA和Cross Border